AmideBio can provide innovative biotech service manufacturing for peptides and proteins using a novel recombinant-chemical hybrid process. From bench scale mg to multi-gram scale, AmideBio can meet your needs by producing higher quality peptides and proteins at lower cost. AmideBio’s patent pending hybrid recombinant-chemical system is scalable and ideally suited for the manufacturing of difficult to produce hydrophobic, toxic, and amyloidogenic peptides no matter what the polypeptide length.

AmideBio has constructed a proprietary set of expression vectors that achieve high yields of target peptides and protein fusions. The expressed target is easily isolated as inclusion bodies from lysed cells. The target peptide/protein fusions are bound to an affinity column where refolding of the target is also possible followed by low cost proprietary chemical cleavage releasing a highly pure target product.